韶能股份(000601.SZ):日昇公司所持7637.93萬股的司法拍賣中止
格隆匯3月24日丨韶能股份(000601.SZ)公佈,2020年2月25日,公司披露了《廣東韶能集團股份有限公司關於持股5%以上股東持有公司部分股份被司法拍賣的進展公告》,公司第三大股東深圳日昇創沅資產管理有限公司(“日昇公司”)持有公司7637.9302萬股被廣東省深圳市福田區人民法院(“福田區法院”)在淘寶網司法拍賣網絡平台進行公開拍賣,拍賣時間為2020年3月24日10時至2020年3月25日10時止(延時除外)。
2020年3月24日,公司在淘寶網司法拍賣網絡平台獲悉:雙方達成和解協議,此次司法拍賣中止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.